|
G |
Chrna4 |
cholinergic receptor nicotinic alpha 4 subunit |
multiple interactions |
ISO |
antimony trioxide inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein co-treated with CHRNB2 protein]] |
CTD |
PMID:22750351 |
|
NCBI chr 3:168,136,246...168,157,839
Ensembl chr 3:168,136,266...168,156,957
|
|
G |
Chrnb2 |
cholinergic receptor nicotinic beta 2 subunit |
multiple interactions |
ISO |
antimony trioxide inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein co-treated with CHRNB2 protein]] |
CTD |
PMID:22750351 |
|
NCBI chr 2:175,181,402...175,189,619
Ensembl chr 2:175,181,402...175,189,619
|
|
G |
Itgam |
integrin subunit alpha M |
increases expression |
ISO |
antimony trioxide results in increased expression of ITGAM protein |
CTD |
PMID:16112521 |
|
NCBI chr 1:182,659,047...182,709,501
Ensembl chr 1:182,659,000...182,709,503
|
|
G |
Map2k4 |
mitogen activated protein kinase kinase 4 |
multiple interactions |
ISO |
MAP2K4 protein affects the reaction [antimony trioxide results in increased activity of MAPK8 protein] |
CTD |
PMID:16112521 |
|
NCBI chr10:50,343,227...50,447,956
Ensembl chr10:50,344,915...50,447,993
|
|
G |
Mapk8 |
mitogen-activated protein kinase 8 |
multiple interactions increases activity |
ISO |
[antimony trioxide co-treated with Buthionine Sulfoximine] results in decreased expression of MAPK8 protein; Buthionine Sulfoximine promotes the reaction [antimony trioxide results in increased activity of MAPK8 protein]; Glutathione deficiency promotes the reaction [antimony trioxide results in increased activity of MAPK8 protein] MAP2K4 protein affects the reaction [antimony trioxide results in increased activity of MAPK8 protein] |
CTD |
PMID:16112521 |
|
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
increases cleavage multiple interactions |
ISO |
antimony trioxide results in increased cleavage of PARP1 protein Glutathione deficiency promotes the reaction [antimony trioxide results in increased cleavage of PARP1 protein] |
CTD |
PMID:16112521 |
|
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
|
|
G |
Pml |
PML nuclear body scaffold |
affects localization multiple interactions increases degradation |
ISO |
antimony trioxide affects the localization of PML protein antimony trioxide promotes the reaction [SUMO1 protein binds to PML protein] antimony trioxide results in increased degradation of PML protein mutant form |
CTD |
PMID:9834237 |
|
NCBI chr 8:58,627,347...58,661,927
Ensembl chr 8:58,628,837...58,658,971
|
|
G |
Rara |
retinoic acid receptor, alpha |
increases degradation |
ISO |
antimony trioxide results in increased degradation of RARA protein mutant form |
CTD |
PMID:9834237 |
|
NCBI chr10:83,883,490...83,928,932
Ensembl chr10:83,893,384...83,928,142
|
|
G |
Sumo1 |
small ubiquitin-like modifier 1 |
affects localization multiple interactions |
ISO |
antimony trioxide affects the localization of SUMO1 protein antimony trioxide promotes the reaction [SUMO1 protein binds to PML protein] |
CTD |
PMID:9834237 |
|
NCBI chr 9:61,078,790...61,108,697
Ensembl chr 9:61,077,435...61,108,761
|
|